Shiuw H. Han

The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with (186)Re-etidronate in hormone-resistant prostate cancer patients with painful bone metastases. Placebo Controlled Rhenium Study.

Shiuw H. Han, John M. H. de Klerk, Suzy Tan et al. · PubMed · 2002 · 90 citations

Medicine, Oncology, Pharmacology +17

Dose escalation study of rhenium-186 hydroxyethylidene diphosphonate in patients with metastatic prostate cancer

John M. H. de Klerk, Bernard A. Zonnenberg, Alfred D. van het Schip et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1994 · 78 citations

Medicine, Oncology, Pharmacology +16

Treatment of metastatic bone pain using the bone seeking radiopharmaceutical Re-186-HEDP.

John M. de Klerk, Bernard A. Zonnenberg, G.H. Blijham et al. · PubMed · 1997 · 33 citations

Medicine, Nuclear Medicine, Pharmacology +17

186Re-etidronate in breast cancer patients with metastatic bone pain.

Shiuw H. Han, B A Zonneberg, John M. de Klerk et al. · PubMed · 1999 · 31 citations

Medicine, Pharmacology, Pharmacotherapy +17

Undetectable Serum Thyroglobulin in a Patient With Metastatic Follicular Thyroid Cancer

ILSE J. R. MERTENS, John M. H. de Klerk, Pierre Zelissen et al. · Clinical Nuclear Medicine · 1999 · 26 citations

Medicine, Nuclear Medicine, Oncology +17